Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Beraprost

An orally active prostacyclin analogue that widens blood vessels and curbs platelet aggregation; launched in Japan in 1992 for peripheral arterial disease, it is also used for pulmonary arterial hypertension. This family brings together the active ingredient and other impurities.

Did you know?Natural prostacyclin lasts only moments in the blood: by replacing its fragile enol ether group with a benzofuran ring, chemists obtained a molecule that is stable for hours and can be taken as a tablet.

BeraprostGo to the active ingredient →
BeraprostActive ingredientBeraprostCat. No. P-B053-001CAS 88430-50-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.